Introduction
Vitamins are required constituents of the human diet because they are synthesised inadequately or not at all in the human body. 1 They form prosthetic groups of enzymes, or serve as their cofactors participating in the metabolism of carbohydrates, fat and proteins with vitamins A and D acting as hormones. 2 The 2017 dietary requirements of vitamins during all stages of life and pregnancy are published in detail in the Nutrient Reference Values publication by the Department of Health and Ageing and The New Zealand Ministry of Health. 3 Manufacturers target common illnesses such as heart disease and specific markets such as post-menopausal women and frequently use prominent personalities in their promotion. The Australian Bureau of Statistics household survey of over 12 000 individuals aged over 2 years of age revealed that in the preceding 24 h, when broken down into various age groups, between 10.5% and 23.4% had taken a vitamin or mineral supplement. 4 In 2016, the complementary industry reports an industry revenue including exports as $4 200 000 000, pharmacy sales being 41%, supermarkets 26% and health food shops 25%. This overview will consider only the fat-soluble vitamins A, D, E and K and the water-soluble ones thiamine B 1 , riboflavin B 2 , niacin B 3 , pyridoxine B 6 , B 12 , folic acid, biotin and vitamin C. Pantothenic acid is often marketed as B 5 and has been included for this reason. It will not consider mineral or other products used in combination with vitamins or megadose vitamin therapy. Nutrient Reference Values mentioned in this article are for healthy non-pregnant or lactating adults and are expressed as adequate intake, recommended daily intake (RDI) and upper limit (UL). Where there is no UL, it is stated as not possible. 3 In this overview of a huge area, marketing and promotional activity was obtained by Google searches and promotional material. Literature searches were undertaken largely using PubMed, Google Scholar and the Cochrane reviews.
Numerous trials of varying size and sophistication have evaluated the effects of various vitamin and mineral supplements in generally healthy populations. From these differing opinions as to benefit can be found used in promotion and can be supported by some of the literature. For example, a large meta-analysis published in the British Medical Journal concluded that 'there was no evidence to support the use of vitamin and antioxidant supplements for the prevention of cardiovascular diseases'. 6 Subgroup analyses, that are often quoted, in the same study revealed that there were some individual studies that showed marginal benefits of some vitamins and these were ones where pharmaceutical companies supplied the supplements.
Numerous investigations involving over 10 000 participants have evaluated the effects of various supplements on malignancies. The Physicians Health Study reported an inverse relationship at the P-value of 0.04 between a multivitamin supplement containing 30 vitamins and minerals and malignancies in physicians but no specific cancer was identified. 7 Other reviews have not found that vitamin or antioxidant supplementation reduces the incidence of malignancies or increases the lifespan. 8, 9 Vitamin A Vitamin A is a generic term for a retinol, retinal and retinoic acid found in animals. The term 'retinoids' has been used to define these substances as well as other compounds with vitamin A-like activity. The provitamin of vitamin A is the plant pigment β-carotene.
Vitamin A is required to maintain the integrity of epithelial cells, a regulator of gene expression in the encoding of proteins, is needed to maintain differentiation of the cornea and is a requirement for photoreceptors in the rod and cone cells. It also has antioxidant properties and numerous effects on the immune system as well as being essential for embryogenesis. 2, 3 Promotional advertising includes prevention of cancer, building immunity, healthy skin production, helping development of the nervous system and improving vision.
Toxicity occurred in Antarctic and Arctic explorers who consumed the livers of seals, huskies or polar bears and can be fatal. It is characterised by raised intracranial pressure, exfoliative dermatitis, nausea and vomiting, diplopia and convulsions. 10 Chronic toxicity has been described in sportspersons 11 and as a complementary therapy. 12 It is associated with teratogenicity and contraception is required for at least a year after taking this drug. 1 Of particular concern are other data that have linked vitamin A to an 18% increased incidence of lung cancer in a study of 29 133 Finnish smokers who received either α-tocopherol 50 mg or β-carotene 20 mg 13 and a 28% increase of lung cancer in a similar study in 18 314 smokers, some of whom had also been exposed to asbestos.
14 A slight but significant increase in cardiac events was also found in both these studies.
There does not appear to be any case for supplementation in otherwise healthy individuals and there is the possibility that it is linked to cancer in some individuals. Particular care is needed not to exceed recommended doses in pregnancy because of the possibility of miscarriage and teratogenicity.
The UL for both sexes in retinol equivalents is 3000 μg/day. In 1848 one of the world's first clinical trials in more than 1000 patients with tuberculosis showed that of those who received a spoon full of cod liver oil three times daily, 19% died or deteriorated compared to 33% in the control group. Active promotion of vitamin D in the United States had resulted in annual sales rising from $50 000 000 in 2005 to $600 000 000 in 2011. 15 From a global perspective vitamin D deficiency may be a worldwide problem. 16 Low vitamin D status has been demonstrated in the elderly and low 25-hydroxy D status has been linked to many acute and chronic disease processes. Increasing the low concentrations does not appear to alter the occurrence or course of the conditions apart from a slight decrease in all-cause mortality in the elderly with low levels of 25hydroxy vitamin D. 17 Several long-term studies are nearing completion that may show some benefits in the areas for which there has been extensive but not evidence-based promotion. 15 Of these long-term studies, a large well designed New Zealand study has recently reported the results of a randomised trial of monthly high-dose therapy. In this community-based study numerous cardiovascular outcomes were measured in an active treatment group of 2558 who received an initial dose of 200 000 IU followed by monthly doses of 100 000 IU against a placebo group of 2552. The authors concluded that high-dose therapy does not prevent cardiovascular disease but that daily dosing requires further study. 18 Epidemiological studies have shown inconsistent relationships between vitamin D and various malignancies. A very large Mendelian randomisation study of 70 563 patients with one of seven malignancies (prostate, breast, lung, colorectal, ovarian, pancreatic and neuroblastoma) and 84 418 controls was unable to find any association between levels of vitamin D and these malignancies. The authors considered that vitamin D supplementation should not be recommended as a means of preventing cancer. 19 Hypervitaminosis D is unusual. It is characterised by hypercalcaemia and impaired renal function and has been reported as a complication of over-the-counter medication use when taken in very large doses. 20 At present there is no case for routine supplementation of vitamin D unless there is a clinical or biochemical indication.
The UL for both sexes is 80 μg/day.
Vitamin E
Vitamin E is a mixture of tocopherols, of which 90% in human tissue is in the form of RRR-α-tocopherol. It is the most abundant natural antioxidant in the lipid phase of cell membranes. 2 Plants synthesise eight different forms of vitamin E, with isometric differences to the synthetic forms. 21 Commercial products are marketed as mixed tocopherols.
Overt clinical deficiency has never been described in normal individuals even on a diet low of the vitamin. Despite this it has been recommended as treatment for a very large number of medical conditions and is the subject of an enormous volume of medical and non-medical literature. Some of the studies have involved coadministration with vitamin C as it participates in the regeneration of α-tocopherol. It is actively promoted for use in all vascular diseases, prevention of numerous malignancies, dementia, slowing ageing, improving sporting performance, protection against air pollutants and many other conditions.
There are only a very small number of adult medical indications, such as rare vitamin E responsive autosomal recessive neurodegenerative disorder, for prescribing vitamin E. 22 A recent meta-analysis of 19 clinical trials involving 135 697 patients' trials by Miller et al. concluded that high doses of ≥400 IU/day (1 IU = 0.67 mg D-α-tocopherol, or 0.9 mg DL-α-tocopherol synthetic) may increase all-cause mortality. 23 Following a Cochrane review with similar conclusions on mortality, researchers supported by the complementary industry in 2017 disagreed with this conclusion and criticised the study on the basis of appropriateness of data sets, validity of methods and generalisability of results. In correspondence, the authors of the Cochrane review strongly disagreed with their conclusion. 24 At present the data show that there is a dose-related increase in mortality and as such supplementation should be avoided. Vitamin E has antiplatelet actions and has also been shown to cause increased haemorrhagic events in patients receiving warfarin. 25 There does not appear to be any benefit in prescribing vitamin E supplementation to otherwise healthy subjects.
The UL for both sexes is 300 α-tocopherol equivalents.
Vitamin K
Vitamin K is a group of compounds that vary in the number of isoprenoid units in their side chain. It circulates as phylloquinone or phytonadione (vitamin K 1 ). The hepatic stores are in the form of menaquinones (vitamin K 2 ) and there is considerable endogenous synthesis of vitamin K by gut bacteria. 2 Its main function is to maintain coagulation status. It has a role in bone mineralisation, being a requirement for the carboxylation of osteocalcin and has been considered as possibly having a role in promoting valvular and arterial decalcification. A Cochrane review was unable to confirm that it had any value in the prevention of cardiovascular diseases. 26 There is considerable promotion for the use of vitamin use for 'bone health' in the social media but its place in the prevention of osteoporosis is not determined. High doses are considered non-toxic in adults. 27 Co-administration with warfarin or similarly acting anticoagulants is contraindicated.
Reference values for daily adequate intake are 70 μg for males and 60 μg for females, but there is no UL steroidogenesis. In addition, it enhances absorption of non-haeme iron and participates in bone mineral metabolism. 2 After absorption it is retained in the body until the daily intake exceeds 400-500 mg/day when no more is reabsorbed in the proximal tubules and urine concentrations progressively rise. This can result in renal calculi that appear to be more common in men than women. 28, 29 Additional adverse effects of high doses include upper gastrointestinal symptoms and diarrhoea. Dialysis patients receiving doses of 500 mg or more may develop hyperoxalaemia.
While not identified until 1912 and isolated in 1928, John Lind's clinical trial on the HMS Salisbury in May 1747 was pivotal in showing that scurvy responded to dietary changes. Vitamin C deficiency is now very rare but not unknown in Australasia. 30 Vitamin C gained enormous popularity as a result of the dual Nobel Laureate Linus Pauling claiming it was effective in preventing some illnesses including the common cold. It is promoted to boost the immune system, lower hypertension, treat lead toxicity, cure cataracts, treat cancer, combat stroke, maintain elasticity of the skin, heal wounds and control the symptoms of asthma.
A Cochrane review of 29 trials involving 11 306 participants, including children, adults, military personnel on subarctic exercises and marathon runners, concluded that the incidence of colds was not reduced but the duration of a cold may be decreased. Routine supplementation with vitamin C was not indicated. 31 Population-based studies have found an inverse relationship between plasma concentrations of vitamin C and vitamin C intake and blood pressure. A recent metaanalysis and subsequent editorial in the same issue of the journal concluded that there was insufficient evidence to recommend vitamin C to lower blood pressure. 32, 33 A further Cochrane review found it had no value in the primary prevention of cardiovascular disease. 34 There are observational studies and favourable case reports in some patients with cancer, but no randomised controlled trials have shown benefit. 35 A recent metaanalysis of randomised controlled trials could not find evidence to support its value in the prevention of malignant diseases. 36 High doses are definitely associated with adverse reactions so there does not seem to be any place for routine supplementation in healthy individuals.
RDI for both sexes is 45 mg/day without an UL.
Thiamine (vitamin B 1 )
Thiamine is essential for carbohydrate metabolism and for the metabolism of branched chain fatty acids.
Deficiency results in beriberi and deficiency does not occur in healthy individuals. 2 Most thiamine is administered with other vitamins and minerals. Parenteral thiamine can occasionally produce allergic reactions. 37 Promotional advertisements describe non-specific symptoms such as fatigue, loss of appetite, numbness as well as enhancing blood circulation.
Therapeutic overdoses caused a syndrome of irritability, insomnia, tachycardia and generalised weakness when regular doses of 20-40 mg/day were prescribed for settlers in the tropics and had been taken for weeks to overcome the effects of their moving from cooler climates. 38 This practice has now ceased and there are no indications for routine supplementation.
The daily RDI for males is 1.2 mg and for females 1.1 mg, without an UL.
Riboflavin (vitamin B 2 )
Riboflavin exists in two active forms: flavin mononucleotide and flavin adenine dinucleotide, and is a requirement for carbohydrate and lipid metabolism. Dietary deficiency causes angular stomatitis, glossitis and dermatitis. High doses appear to be free of adverse effects apart from sometimes causing gastrointestinal symptoms such as abdominal pain and diarrhoea. 39 Riboflavin has been recommended for migraine. This is a condition where there is a high placebo response and clinical trials have shown variable results, with one review concluding 'there is insufficient evidence to make recommendations regarding B 2 as an adjunct therapy for preventing migraine symptoms in adults' and another considering it may reduce frequency of attacks. 40, 41 In addition, riboflavin is promoted for eye health (usually prevention of cataracts), preventing anaemia, maintenance of energy levels, protecting the skin and prevention of cancer but none of these claims has a reliable evidence base.
There is no UL stated for riboflavin.
Niacin (vitamin B 3 )
Nicotinic acid is the generic name for nicotinic acid and is converted to nicotinamide. In the form of NAD + and NADP + it is essential for many oxidoreductase reactions.
As it can be synthesised from tryptophan it may not be considered a true vitamin. Deficiency causes the 4D's of pellagra: dermatitis, diarrhoea, dementia and death. Therapeutic doses raise high-density lipoprotein cholesterol and were commonly used to treat vascular disease, but these have now been largely discontinued because of lack of efficacy as well as its adverse reaction profile. 42 It is promoted for numerous indications including lowering cholesterol, improving the circulation, improving energy levels and enhancing cognition. Doses are limited by adverse effects of flushing and nausea and high doses cause hepatotoxicity.
The UL for both sexes is 35 mg niacin equivalents.
Pantothenic acid (vitamin B 5 )
Panthothenic acid is also known as vitamin B 5 and is a component of coenzyme A and phosphopantetheine. It is involved in the metabolism of fatty acids, cholesterol, steroids and the acetylation of proteins. 2 Experimentally induced deficiency causes depression, muscle cramping, ataxia and 'burning feet'. 43, 44 Advertisements include the 'alleviation' of conditions such as asthma, hair loss, allergies, stress and anxiety, respiratory disorders and heart problems.
There are no well defined indications for its use as a dietary supplement.
There is no UL for panthothenic acid.
Pyridoxine (vitamin B 6 )
Vitamin B 6 is a mixture of pyridine (an alcohol), pyridoxal (an alcohol), pyridoxamine and 5-phosphate esters. The phosphate is the major active form and is a cofactor, particularly for amino acid metabolism and many other reactions. 2 It is indicated for sideroblastic anaemia, homocystinuria and prevention of isoniazidinduced peripheral neuropathy. Deficiency causes depression, irritability and depression and later convulsions and coma. A hypochromic microcytic anaemia may also develop. 1 In addition, it is used in rare cases of refractory epilepsy in children. 45 Advertisements include the prevention of vascular disease, premenstrual tension, stabilising diabetes and improving brain function.
A Cochrane review did not find any evidence it improved cognition but did not find any severe adverse effects. 46 A sensory peripheral neuropathy develops with long-term high-dose use and has been described in the situation of vitamin supplementation for chronic disease. 47 The recent finding that high-dose B 6 >20 mg/day was associated with an increased risk of lung cancer, particularly in smokers, and is a serious cause for concern. 48 The UL for both sexes is 50 mg.
Biotin
Biotin is also known as vitamin B 7 , vitamin H and coenzyme R. It is a coenzyme in carboxylation reactions and is important in lipogenesis, gluconeogenesis and the catabolism of branched chain amino acids. It is synthesised largely by gut bacteria. Deficiency is rare but levels fall during pregnancy. 1, 2 Biotin is extensively promoted. Indications for use include supporting healthy metabolism, improving glucose tolerance and balancing blood sugar, maintaining healthy skin and nails, preventing cognitive decline, maintaining a healthy cardiovascular system and supporting thyroid and adrenal function.
Apart from a biotin-thiamin-responsive neurological syndrome and its preliminary use in multiple sclerosis, there are no indications for supplementation. 49 High doses appear free of adverse reactions but may alter thyroid function tests. 50 There is no UL for biotin.
Vitamin B 12
Vitamin B 12 is a cofactor for methionine synthase and Lmethyl-malonyl-CoA mutase and is essential for erythropoiesis, initial myelination and later maintenance of the central nervous system. Vitamin B 12 deficiency results in syndrome of megaloblastic anaemia and myelopathy in the spinal chord. 51 There is considerable promotion for supplementation in sport for which there is no substantial support. The American Food and Nutrition Board in the United States recommends that healthy older adults should consider supplementation on the basis that 10-30% of people over 50 may be unable to absorb naturally occurring B 12 .
51
The relationship between mild B 12 and age-related cognitive decline is uncertain with a Cochrane review finding that supplementation with B 12 improved cogitative function in demented patients with a low level of B 12 . 52 Although the hydroxycobalamin formulation appears to be relatively risk free, allergic reactions and diarrhoea have been reported with low doses. Large doses used for non-clinical reasons are reported to cause nausea, vomiting, hypertension, bradycardia and anaphylaxis. 53 The finding of a twofold increased lung cancer in males receiving >55 μg/day over a period of 10 years is a cause for concern. 48 Apart from the recommendation by a US department, there does not appear to be any strong indication or proven benefit in routine supplementation with vitamin B 12 in healthy adults.
There is no UL for B 12 .
Folic acid
Folic acid participates in one-carbon transfers such as methylation in some synthetic pathways (e.g. choline) and is essential for the synthesis of purines and the pyrimidine thymine. 1,2 Folate supplementation has been undertaken in some foods in Australia and New Zealand since 1996 to decrease the incidence of neural tube defects.
Vitamin supplements, toxicity and promotion
It is promoted to improve numerous conditions, including male and female fertility, Alzheimer disease and prevention of heart disease, as well as to improve sporting performance. There is little evidence to support any of these claims. Concerns have been expressed about the possible links between folate supplementation and carcinogenesis. The 2014 joint statement from the Cancer Society of New Zealand and the Cancer Council of Australia considered that 'people with existing bowel adenomas and those with an increased risk of developing bowel adenomas should avoid taking high dose above the upper limit of 1 mg/day of supplements that contain folic acid'. 54 This possible effect is included by some manufacturers in their advertisements.
The UL for both sexes is 1000 μg.
Conclusion
Most published data have been obtained from generally healthy populations where variables such adequate diet, exercise and other life style factors may influence the results. These present data may not be applicable to some poorer communities. In similar populations to those studied, excluding pregnant and lactating women, it is very hard to justify the use of vitamin supplementation in healthy individuals with a recommended dietary intake of nutrients as published in the Australian Dietary Guidelines. 3 Ultra-endurance athletes and others who have extreme training programmes and competition events have special dietary requirements but they do not need pharmaceutical products. Vitamin D is usually prescribed when there is a biochemical measure to recommend its prescription. Despite exaggerated claims made about vitamin E, the association of increased mortality with high doses is a cause for concern and patients should be informed accordingly. The carcinogenic properties of vitamin A and folic acid are probably confined to subpopulations. The more recently reported effects of pyridoxine and vitamin B 12 relate to high doses and may require more supporting data but are cause for concern. Severe adverse effects to some vitamin preparations are uncommon but occur when very large doses have been consumed. The ULs suggested for vitamins C and B 12 as not possible in the Nutrient Reference Values may need revision in view of the possible adverse effects of high doses.
